The novel synonymous variant in LIPA gene affects splicing and causes lysosomal acid lipase deficiency

Mol Genet Metab. 2019 Jul;127(3):212-215. doi: 10.1016/j.ymgme.2019.06.005. Epub 2019 Jun 15.

Abstract

Lysosomal acid lipase deficiency (LALD; MIM#278000) is a continuum of autosomal recessive diseases caused by defects in the gene LIPA and historically divided into two phenotypes: severe infantile-onset form called Wolman disease (WD) and childhood/adult-onset form known as cholesteryl ester storage disease (CESD). We report a novel synonymous homozygous variant c.600G > A in LIPA of a patient with LALD. Functional analysis of the patient cDNA and minigene assay revealed this variant as the cause of exonic cryptic splice site activation and 63 b.p. deletion in exon 6. To investigate the impact of this in-frame deletion on protein function, we performed 3D modeling of the human lysosomal acid lipase and showed the alteration of highly conservative region in close proximity to protein active site, which may completely eliminate the enzymatic activity. Using transcript specific real-time quantitative PCR method, we evaluated the relative ratio of the patient's wild type transcript isoform which is significantly reduced and correlates with severe childhood-onset variant of LALD.

Keywords: Cholesteryl ester storage disease; Cryptic splice site; Functional analysis; Minigene assay; Quantitative real-time PCR.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child, Preschool
  • Exons
  • Female
  • Genetic Variation*
  • Humans
  • Infant
  • Mutation*
  • Phenotype
  • RNA Splicing*
  • Sterol Esterase / genetics*
  • Wolman Disease / etiology*
  • Wolman Disease / genetics*

Substances

  • LIPA protein, human
  • Sterol Esterase

Supplementary concepts

  • Lysosomal acid lipase deficiency